Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Benjamin Schilling
Introduction
Benjamin Schilling is a notable inventor based in Culver City, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of two patents to his name, Schilling's work focuses on enhancing immune responses through innovative methods.
Latest Patents
Schilling's latest patents include the development of Anti-B7-H4 antibodies and methods. These patents describe compositions, methods, and uses of recombinant B7-H4 protein or binding motifs that can reduce the immune suppression effect of B7-H4 in relation to T cell activation, proliferation, and conversion. The recombinant B7-H4 protein is designed with multiple mutations in the N-glycosylation residue to minimize its inhibitory effect on T cell activation and proliferation. Furthermore, the recombinant protein includes binding motifs to B7-H4 protein, which consist of a binding motif to the IgC domain and another to the IgV domain, allowing for concurrent reduction of immune-suppressive effects by the two Ig-like domains.
Career Highlights
Benjamin Schilling is currently employed at Nantbio, Inc., where he continues to advance his research in immunology and biotechnology. His work is pivotal in developing new therapeutic strategies that can potentially improve patient outcomes in various diseases.
Collaborations
Throughout his career, Schilling has collaborated with esteemed colleagues,
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.